[Experimental eosinophilia in rats released by hexadimethrine bromide].
D000818:Animals; D001965:Bromides; D004802:Eosinophilia / Q000139:chemically induced*; D005260:Female; D006493:Heparin / Q000494:pharmacology; D006494:Heparin Antagonists; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007275:Injections, Intravenous; D007328:Insulin / Q000494:pharmacology; D007964:Leukocytosis / Q000139:chemically induced; D008297:Male; D008357:Mannomustine / Q000009:adverse effects; D008407:Mast Cells / Q000187:drug effects*; D009538:Nicotine / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000037:antagonists & inhibitors / Q000633:toxicity*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology
D001965:Bromides; D006494:Heparin Antagonists; D006634:Histamine H1 Antagonists; D007328:Insulin; D000644:Quaternary Ammonium Compounds; D012701:Serotonin; D009538:Nicotine; D006493:Heparin; D011239:Prednisolone; D008357:Mannomustine
Experimentell durch Hexadimethrinbromid ausgelöste Eosinophilie bei Ratten.